Lamivudine, commonly called 3TC, is an antiretroviral medication used to prevent and treat HIV/AIDS. It is also used to treat chronic hepatitis B when other options are not possible. It is effective against both HIV-1 and HIV-2. It is typically used in combination with other antiretrovirals such as zidovudine and abacavir. Lamivudine may be included as part of post-exposure prevention in those who have been potentially exposed to HIV. Lamivudine is taken by mouth as a liquid or tablet.

Property Value
dbo:abstract
  • Lamivudine, commonly called 3TC, is an antiretroviral medication used to prevent and treat HIV/AIDS. It is also used to treat chronic hepatitis B when other options are not possible. It is effective against both HIV-1 and HIV-2. It is typically used in combination with other antiretrovirals such as zidovudine and abacavir. Lamivudine may be included as part of post-exposure prevention in those who have been potentially exposed to HIV. Lamivudine is taken by mouth as a liquid or tablet. Common side effects include nausea, diarrhea, headaches, feeling tired, and cough. Serious side effects include liver disease, lactic acidosis, and worsening hepatitis B among those already infected. It is safe for people over three months of age and can be used during pregnancy. The medication can be taken with or without food. Lamivudine is a nucleoside reverse transcriptase inhibitor and works by blocking the HIV reverse transcriptase and hepatitis B virus polymerase. Lamivudine was patented in 1995 and approved for use in the United States in 1995. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication. The wholesale cost in the developing world as of 2014 is about US$0.06 per day. As of 2015 the cost for a typical month of medication in the United States is more than $200. (en)
dbo:alternativeName
  • Epivir, others (en)
dbo:bioavailability
  • 86.000000 (xsd:float)
dbo:casNumber
  • 134678-17-4
dbo:chEMBL
  • 141
dbo:drugbank
  • DB00709
dbo:fdaUniiCode
  • 2T8Q726O95
dbo:kegg
  • D00353
dbo:medlinePlus
  • a696011
dbo:pubchem
  • 73339
dbo:thumbnail
dbo:wikiPageEditLink
dbo:wikiPageExternalLink
dbo:wikiPageExtracted
  • 2019-09-22 02:24:07Z (xsd:date)
dbo:wikiPageHistoryLink
dbo:wikiPageID
  • 770039 (xsd:integer)
dbo:wikiPageLength
  • 15645 (xsd:integer)
dbo:wikiPageModified
  • 2019-09-22 02:23:42Z (xsd:date)
dbo:wikiPageOutDegree
  • 79 (xsd:integer)
dbo:wikiPageRevisionID
  • 917061671 (xsd:integer)
dbo:wikiPageRevisionLink
dbp:wikiPageUsesTemplate
dct:subject
rdf:type
rdfs:comment
  • Lamivudine, commonly called 3TC, is an antiretroviral medication used to prevent and treat HIV/AIDS. It is also used to treat chronic hepatitis B when other options are not possible. It is effective against both HIV-1 and HIV-2. It is typically used in combination with other antiretrovirals such as zidovudine and abacavir. Lamivudine may be included as part of post-exposure prevention in those who have been potentially exposed to HIV. Lamivudine is taken by mouth as a liquid or tablet. (en)
rdfs:label
  • Lamivudine (en)
rdfs:seeAlso
owl:sameAs
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is foaf:primaryTopic of